Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-017967
Filing Date
2016-05-05
Accepted
2016-05-05 16:06:12
Documents
48
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cnat-10q_20160331.htm 10-Q 725987
2 EX-10.1 cnat-ex101_92.htm EX-10.1 19022
3 EX-10.2 cnat-ex102_93.htm EX-10.2 122512
4 EX-31.1 cnat-ex311_7.htm EX-31.1 10753
5 EX-31.2 cnat-ex312_6.htm EX-31.2 11930
6 EX-32.1 cnat-ex321_8.htm EX-32.1 6589
7 EX-32.2 cnat-ex322_9.htm EX-32.2 7456
  Complete submission text file 0001564590-16-017967.txt   3221521

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cnat-20160331.xml EX-101.INS 624526
9 XBRL TAXONOMY EXTENSION SCHEMA cnat-20160331.xsd EX-101.SCH 23811
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnat-20160331_cal.xml EX-101.CAL 30719
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnat-20160331_def.xml EX-101.DEF 68779
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnat-20160331_lab.xml EX-101.LAB 216752
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnat-20160331_pre.xml EX-101.PRE 158215
Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Filer) CIK: 0001383701 (see all company filings)

EIN.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36003 | Film No.: 161623675
SIC: 2834 Pharmaceutical Preparations